Time frame of pancreas allograft rejection: An immunogenetic analysis in MHC-disparate, presensitized inbred rat strains

Transplantation Proceedings

Volumn 35, Issue 8, 2003, Pages 3147-3152

  Litmathe, J ^a   Bektas, H ^b   Jorns A ^b   Klempnauer, J ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ACUTE GRAFT REJECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGENIC VARIATION; ARTICLE; CONTROLLED STUDY; EXOCRINE SECRETION; EXPERIMENTAL MODEL; GRAFT REJECTION; HISTOPATHOLOGY; HYPERGLYCEMIA; INBRED STRAIN; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; NONHUMAN; PANCREAS DUCT LIGATION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RAT; RAT STRAIN; RECIPIENT; RECURRENT DISEASE; SKIN SENSITIZATION; SPECIES COMPARISON; STREPTOZOCIN DIABETES; TISSUE SECTION; TRANSPLANTATION TOLERANCE;

EID: 0346500847     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2003.10.027     Document Type: Article

References (36)

1. Kazi A., Blonde L. Classification of diabetes mellitus. Clin Lab Med. 21:2001;1.
2. Lorenz R.A. Modern insulin therapy for type 1 diabetes mellitus. Prim Care. 26:1999;917.
3. McMillan D.E. Development of vascular complications in diabetes. Vasc Med. 2:1997;132.
4. Raptis A.E., Viberti G. Pathogenesis of diabetic nephropathy. Exp Clin Endocrinol Diabetes. 109:(Suppl 2):2001;424.
5. Greene D.A., Stevens M.J., Feldmann E.L. Diabetic neuropathy scope of a syndrome . Am J Med. 107:1999;2S.
6. White S.A., Nicholson M.L., London N.J. Vascularized pancreas allotransplantation - clinical indications and outcome. Diabet Med. 16:1999;533.
7. Petruzzo P., Da Silva M., Feitosa L.C., et al. Simultaneous pancreas-kidney transplantation portal venous versus systemic venous drainage of the pancreas allograft . Clin Transplant. 14:2000;287.
8. Stratta R.J. Review of immunosuppressive usage in pancreas transplantation. Clin Transplant. 13:1999;1.
9. Hiller W.F., Klempnauer J. Comparative evaluation of the immunogenecity of isolated islets of Langerhans and the whole pancreas. Transplant Proc. 21:1989;2678.
10. Hiller W.F., Klempnauer J., Steiniger B. Immunogenetic analysis of renal subcapsular islet transplantation in the rat. Transplant Proc. 21:1989;3309.
11. Hart D.N.J., Fabre J.W. Demonstration and characterization of la-positive dendritic cells in the interstitial connective tissue of rat heart and other tissues, but not brain. J Exp Med. 154:1981;347.
12. Gruessner AC, Sutherland DE: Pancreas transplant outcomes for US cases reported to the united network for organ sharing (UNOS) and non US cases reported to the international pancreas transplant registry (IPTR) as of Oct. 2000. Clin Transp 45, 2000.
13. Günther E., Stark O. The major histocompatibility system of the rat (Ag-B of H-1 system). Götze D. The Major Histocompatibility System in Man and Animals. 1977;207 Spriner, Berlin, Heidelberg, New York.
14. Günther E. Immunogenetic aspects of organ transplantation. Thiede A., Deltz E., Engemann R. Microsurgical Models in Rats for Transplantation Research. 1985;83 Springer, Berlin, Heidelberg, New York.
15. Gill T.J., Kunz H.W., Misra D.N., et al. The major histocompatibility complex of the rat. Overview. Transplantation. 43:1987;773.
16. Lee S., Tung K.S., Koomans H., et al. Pancreaticoduodenal transplantation in the rat. Transplantation. 13:1972;421.
17. Nowaza M., Weil R. III, McIntosh R., et al. Vascularized pancreas transplantation of the rat pancreas without duodenum. Transplantation. 17:1974;137.
18. Klempnauer J., Settje A. Vascularized pancreas transplantation in the rat - details of the microsurgical techniques, results and complications. Transpl Int. 2:1989;84.
19. Gorer P.A., O'Gorman P. The cytotoxic activity of isoantibodies in mice. Transpl Bull. 3:1956;142.
20. Dubernard J.M., Tajra L.C., Lefrancois N., et al. Pancreas transplantation results and indications . Diabetes Metab. 24:1998;195.
21. Klempnauer J., Bektas H., Hiller W.F., et al. Spontaneous tolerance induced by MHC class I incompatible kidney grafts for subsequent pancreas transplants. Transplant Proc. 25:1993;2856.
22. Klempnauer J., Vogt P., Hiller W.F. Donor-specific tolerance induced by non major histocompatibility complex kidney grafts for subsequent pancreas transplants. Transplant Proc. 25:1993;373.
23. Schulak J.A., Henry M.L., Munda R., et al. Pancreas transplantation in Ohio a 15-year outcomes analysis . Surgery. 130:2001;546.
24. Lück R., Klempnauer J., Ehlerding G., et al. Significance of portal venous drainage after whole organ pancreas transplantation for endocrine graft function and prevention of diabetic nephropathy. Transplantation. 50:1990;394.
25. Klempnauer J., Steiniger B., Wonigkeit K., et al. Immunological characteristics of vascularized pancreas transplantation. Thiede A., Deltz E., Engemann R. Microsurgical models in rats for transplantation research. 1985;165 Springer, Berlin, Heidelberg.
26. Monaco J.J. Structure and function of genes in the MHC class II region. Curr Opin Immunol. 5:1993;17.
27. Geraghty D.E. Structure of HLA class I region and expression of its resident genes. Curr Opin Immunol. 5:1993;3.
28. Muhlethaler-Mottet A., Otten L.A., Steimle V., et al. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J. 16:1997;2851.
29. Jemison L.M., Williams S.K., Lublin F.D., et al. Interferon gamma inducible endothelial cell class II MHC expression correlates with strain- and site-specific susceptibility to experimental allergic encephalomyelitis. J Neuroimmunol. 47:1993;15.
30. Metzger R., Mempel T., Joppich I., et al. Organ-specific distribution of major histocompatibility antigens in rats. Pediatr Surg Int. 16:2000;285.
31. Korpelainen E.I., Gamble J.R., Smith W.B., et al. Interferon gamma upregulates IL-3 receptor expression in human endothelial cells and synergizes with IL-3 in stimulating MHC class II expression and cytokine production. Blood. 86:1995;176.
32. Hiller W.F., Klempnauer J. Comparative evaluation of the immunogenecity of isolated islets of Langerhans and the whole pancreas. Transplant Proc. 21:1989;2678.
33. Hiller W.F., Steiniger B., Klempnauer J. The role of histocompatibility antigens in transplantation of isolated islets of Langerhans in the rat. Diabetes. 42:1993;90.
34. Takeda A., Uchida K., Haba T., et al. Acute humoral rejection of kidney allografts in patients with a positive flow cytometry crossmatch (FCXM). Clin Transplant. 14:(Suppl 3):2000;15.
35. Sakorafas G.H., Tsiotos G.G., Sarr M.G. Ischemia/reperfusion-induced pancreatitis. Dig Surg. 17:2000;3.
36. Montgomery R.A., Zachary A.A., Racusen L.C., et al. Plasmapheresis and intravenous globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation. 70:2000;887.